Help us to stop prostate diseases ruining lives
Research Programme in 2003

Grants Awarded in financial year 2003    (Total of £305,041)


A STUDY OF THE EPIGENETIC REGULATION OF THE TUMOUR SUPPRESSOR DAB2 AND ITS INTERACTING PARTNERS IN PROSTATE CANCER
G2003/01

Professor D. E. Neal and Alan Aitchison

Addenbrooke's Hospital, Cambridge

Show research Summary


DISBURSEMENT FOR SPONSORSHIP OF THE FOSTER LECTURE FOR THE BRITISH UROLOGICAL GROUP AT THE 5TH WORLD CONGRESS OF UROLOGICAL RESEARCH IN SEPTEMBER 2003
G2003/02

British Prostate Group


IMPORTANCE OF INTERLEUKIN-B IN CONFERRING CHEMO-RESISTANCE IN PROSTATE CANCER IMPLICATIONS FOR RESPONSE TO CONVENTIONAL CHEMOTHERAPY AGENTS
G2003/03

Dr David Waugh

Belfast City Hospital

Show research Summary


GRANT FOR THE PURCHASE OF STERILE EQUIPMENT FOR USE IN PROSTATITIS PILOT STUDY
G2003/04

Dr Zara Gall

Blackburn Royal Infirmary


EVALUATION OF NOVEL MARKERS IN PREDICTING METASTATIC BONE DISEASE IN PROSTATE CANCER
G2003/05

Joshua Phillips

Royal Hallamshire Hospital, Sheffield

Show research Summary


THE ROLE OF THE NOVEL INHIBITORY VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) ISOFORM (VEGF 165B) IN THE TREATMENT OF PROSTATE CANCER
G2003/06

Mr David Gillatt, Dr Steven Harper, Dr David Bates

Southmead Hospital, Bristol

Show research Summary


RISK FACTORS FOR BENIGN PROSTATIC HYPERPLASIA AMONG MIGRANT BANGLADESHI MEN IN LONDON
G2003/07

Dr Gillian R. Bentley

University College London

Show research Summary


Continuation of project G2002/01: THE EFFECTS OF BISPHOSPHONATES ON ANGIOGENESIS FACTORS, MARKERS OF BONE TURNOVER AND CELLS OF THE INNATE IMMUNE SYSTEM IN PROSTATE CANCER PATIENTS
G2003/08

Mr Jonathan Coxon

St George's Hospital Medical School, London

Show research Summary


ACCURATE DIAGNOSIS AND STAGING OF PROSTATE CANCER USING RT-PCR IDENTIFICATION OF SENSITIVE SPECIFIC MARKERS
G2003/09

Dr Christiane Fenske

St George's Hospital Medical School, London

Show research Summary


CHARACTERISATION OF LOSS OF HETEROZYGOSITY ON CHROMOSOME 18q AND ALTERATIONS IN THE WNT SIGNALLING PATHWAY IN PROSTATE CARCINOGENESIS
G2003/10

Dr George Yardy, Sir Walter Bodmer & Mr Simon Brewster

Institute of Molecular Medicine, John Radcliffe Hospital, Oxford

Show research Summary


Continuation of project G2002/17: MOLECULAR GENETIC CHANGES IN PROSTATE CANCER: GUIDES TO CLINICAL MANAGEMENT
G2003/11

Mark Feneley, Simon Bott, Magail Williamson and A. Freeman

University College London, Institute of Urology

Show research Summary


THE IMPACT OF CYTOTOXIC CD* + LYMPHOCYTES REACTIVE TO PSA ON RESIDUAL DISEASE IN PATIENTS WITH PROSTATE CANCER
G2003/12

Dr Anthony W. Rowbottom, Dr P. E. Williams and Dr H. Kynaston

University Hospital of Wales, Cardiff

Show research Summary


Continuation of project G2002/09: THE APPLICATION OF IMAGE PROCESSING AND COMPARISON OF 3-D (TRUS) AND ENHANCED (E-MRI) IN STAGING CLINICALLY CONFINED PROSTATE CANCER
G2003/13

Mr Santbir S Mehta, D C Barber, E van Beek, J Goepel, F C Hamdy

Royal Hallamshire Hospital, Sheffield

Show research Summary


A COMPARISON OF THE BASAL CELL MARKERS LP34, P63 AND MASPIN IN THE DIFFERENTIAL DIAGNOSIS OF PROSTATE CANCER IN NEEDLE CORE BIOPSIES
G2003/14

Claire Krelle

Wycombe General Hospital, High Wycombe

Show research Summary


Total Grants Awarded for Prostate Research in financial year 2005 is £477,184